Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Keen Eye

Keen Eye
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$6.74M LATEST DEAL AMOUNT
3 INVESTORS
Description

Operator of a health tech company intended to build machine learning technology for translational and clinical research. The company's technology platform allows doctors and biologists to reproduce and extend their visual expertise, notably by identifying signals with a high predictive value that are yet difficult to detect, allowing medical practitioners to save valuable time in day-to-day decision-making, whether it is to diagnose, screen disease or evaluate the effectiveness of a drug in a more precise and standardized way

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare Services
Primary Office
  • Incubator Institute of Vision
  • 74 rue du Faubourg Saint Antoine
  • 75012 Paris
  • France
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Keen Eye’s full profile, request a free trial.

Keen Eye Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 29-Apr-2019 $6.74M 00.000 000.00 Completed Generating Revenue
6. Early Stage VC 12-Dec-2016 00.00 00.000 00.000 Completed Generating Revenue
5. Angel (individual) 15-Jun-2016 000.00 00000 00.000 Completed Startup
4. Angel (individual) 01-Dec-2015 000.00 00000 00.000 Completed Startup
3. Angel (individual) 23-May-2015 000.00 00000 00.000 Completed Startup
2. Angel (individual) 26-Dec-2014 $142K $142K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Keen Eye Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
P-2019 Shares 00,000 00.000000 0000.0 0000.0 00 0000.0 00.000
P-2016 Shares 00,000 00.000000 000.00 000.00 00 000.00 00.000
O Shares 0,000 00.000000 000.00 000.00 000.00 0.000
O Shares 0,000 00.000000 000.00 000.00 000.00 0.000
O Shares 000 00.000000 000.00 000.00 000.00 0.000
O Shares 3,800 $0.011230 $33.97 $33.97 $33.97 1.71%
O Shares 100,000 $0.011230
To view this company’s complete Cap Table, request access »

Keen Eye Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Crédit Mutuel Equity Growth/Expansion Minority 000 0000 000000 0
Seventure Partners Venture Capital Minority 000 0000 000000 0
Incubateur Insitut de La Vision Accelerator/Incubator Minority 000 0000 000000 0

Keen Eye Executive Team (5)

Name Title Board
Seat
Contact
Info
Sylvain Berlemont Ph.D Founder & Chief Executive Officer
Mathias Monnerville Chief Technology Officer
Leandro Almeida Chief Scientific Officer
Julien Alvo Chief Business Officer
Philippe Tramoy Member of the Strategic Advisory Board

Keen Eye Board Members (2)

Name Representing Role Since Contact
Info
Gaudenz Danuser Ph.D Self Chairman 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »